It has recently been shown that activated IFNγ signaling, in the experimental context of infection or exogenous administration, is a strong driver of the clonal expansion of cells carrying loss-of-function mutations in the gene DNMT3A, by far the most prevalent mutation found in CH. This evidence concerns the gene DNMT3A and cyclic hematopoiesis.